Optic Nerve Diseases D009901

Diseases [C] » Nervous System Diseases [C10] » Cranial Nerve Diseases » Optic Nerve Diseases

Diseases [C] » Eye Diseases [C11] » Optic Nerve Diseases

Description

Conditions which produce injury or dysfunction of the second cranial or optic nerve, which is generally considered a component of the central nervous system. Damage to optic nerve fibers may occur at or near their origin in the retina, at the optic disk, or in the nerve, optic chiasm, optic tract, or lateral geniculate nuclei. Clinical manifestations may include decreased visual acuity and contrast sensitivity, impaired color vision, and an afferent pupillary defect.   MeSH

Subtype Terms (9)

Low Tension Glaucoma
10 drugs (7 approved, 3 experimental)

Optic Atrophy
12 drugs (6 approved, 6 experimental)

Optic Disk Drusen
 

Optic Nerve Hypoplasia
1 experimental drug

Optic Nerve Injuries
4 drugs (2 approved, 2 experimental)

Optic Nerve Neoplasms
 

Optic Neuritis
24 drugs (17 approved, 7 experimental)

Optic Neuropathy, Ischemic
24 drugs (18 approved, 6 experimental)

Papilledema
7 approved drugs


Phase 4 Indicated Drugs (1)

Phase 3 Indicated Drugs (2)

Phase 2 Indicated Drugs (1)


Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.